| 2026-04-02 |
股东大会：
将于2026-05-14召开股东大会
会议内容 ▼▲
- 1.To elect the eight director nominees named in the Proxy Statement to the Celcuity Board of Directors, to serve until the next annual meeting of stockholders and the election of such director’s successor, or such director’s earlier death, resignation or removal;
2.To ratify the appointment of Boulay PLLP as Celcuity’s independent registered public accounting firm for the year ending December 31, 2026;
3.To approve, on an advisory basis, named executive officer compensation;
4.To approve the Celcuity Inc. 2026 Stock Incentive Plan;
5.To approve the Celcuity Inc. Amended and Restated 2017 Employee Stock Purchase Plan;
6.To transact any other business as may properly come before the Annual Meeting or any adjournments thereof, including matters incident to the conduct of the Annual Meeting.
|
| 2026-03-26 |
详情>>
股本变动：
变动后总股本4833.67万股
|
| 2026-03-26 |
详情>>
业绩披露：
2025年年报每股收益-3.79美元,归母净利润-1.77亿美元,同比去年增长-58.39%
|
| 2026-03-25 |
财报披露：
美东时间 2026-03-25 盘后发布财报
|
| 2026-02-11 |
详情>>
内部人交易：
ROMP CHARLES R股份增加215.00股
|
| 2025-11-13 |
详情>>
业绩披露：
2025年三季报(累计)每股收益-2.81美元,归母净利润-1.26亿美元,同比去年增长-67.81%
|
| 2025-08-14 |
详情>>
业绩披露：
2025年中报每股收益-1.9美元,归母净利润-8226.5万美元,同比去年增长-81.46%
|
| 2025-07-28 |
复牌提示：
2025-07-28 06:55:00 停牌，复牌日期 2025-07-28 07:30:00
|
| 2025-05-15 |
详情>>
业绩披露：
2025年一季报每股收益-0.86美元,归母净利润-3699.7万美元,同比去年增长-71.18%
|
| 2025-04-01 |
股东大会：
将于2025-05-13召开股东大会
会议内容 ▼▲
- 1.To elect the seven director nominees named in the Proxy Statement to the Celcuity Board of Directors, to serve until the next annual meeting of stockholders and the election of such director’s successor, or such director’s earlier death, resignation or removal;
2.To ratify the appointment of Boulay PLLP as Celcuity’s independent registered public accounting firm for the year ending December 31, 2025;
3.To approve, on an advisory basis, named executive officer (NEO) compensation;
4.To approve a 3,000,000 share increase to the Celcuity Inc. Amended and Restated 2017 Stock Incentive Plan;
5.To transact any other business as may properly come before the meeting or any adjournments thereof, including matters incident to the conduct of the meeting.
|
| 2025-03-31 |
详情>>
业绩披露：
2024年年报每股收益-2.83美元,归母净利润-1.12亿美元,同比去年增长-75.26%
|
| 2024-11-14 |
详情>>
业绩披露：
2024年三季报(累计)每股收益-1.96美元,归母净利润-7512.61万美元,同比去年增长-67.2%
|
| 2024-08-28 |
股东大会：
将于2024-10-07召开股东大会
会议内容 ▼▲
- 1.To approve an amendment to our Certificate of Incorporation to increase the authorized number of shares of common stock, $0.001 par value per share (“Common Stock”), from 65,000,000 shares to 95,000,000 shares (the “Authorized Share Increase”);
2.To approve the adjournment of the Special Meeting to a later date and time, if necessary, to permit further solicitation and vote of proxies if, based upon the tabulated vote at the time of the Special Meeting, there are not sufficient votes to approve the Authorized Share Increase;
3.To transact any other business as may properly come before the meeting or any adjournments thereof, including matters incident to the conduct of the Special Meeting.
|
| 2024-08-14 |
详情>>
业绩披露：
2024年中报每股收益-1.26美元,归母净利润-4533.43万美元,同比去年增长-70.9%
|
| 2024-05-15 |
详情>>
业绩披露：
2024年一季报每股收益-0.64美元,归母净利润-2161.25万美元,同比去年增长-81.03%
|
| 2024-03-28 |
股东大会：
将于2024-05-09召开股东大会
会议内容 ▼▲
- 1.To elect the seven director nominees named in the Proxy Statement to the Celcuity Board of Directors, to serve until the earlier of the next annual meeting of stockholders, the election of such director’s successor, or such director’s death, resignation or removal;
2.To ratify the appointment of Boulay PLLP as Celcuity’s independent registered public accounting firm for the year ending December 31, 2024;
3.To approve, on an advisory basis, named executive officer (NEO) compensation;
4.To recommend, on an advisory basis, the frequency of votes on named executive officer compensation;
5.To approve a 1,500,000 share increase to the Celcuity Inc. Amended and Restated 2017 Stock Incentive Plan;
6.To approve an amendment to the Celcuity Inc. Amended and Restated 2017 Stock Incentive Plan increasing by 250,000 the number of incentive award shares that may be granted in any calendar year to any one eligible recipient;
7.To transact any other business as may properly come before the meeting or any adjournments thereof, including matters incident to the conduct of the meeting.
|
| 2024-03-27 |
详情>>
业绩披露：
2023年年报每股收益-2.69美元,归母净利润-6377.91万美元,同比去年增长-57.99%
|
| 2023-11-13 |
详情>>
业绩披露：
2023年三季报(累计)每股收益-2.05美元,归母净利润-4493.06万美元,同比去年增长-56.07%
|
| 2023-03-31 |
股东大会：
将于2023-05-11召开股东大会
会议内容 ▼▲
- 1.To elect the seven director nominees named in the Proxy Statement to the Celcuity Board of Directors, to serve until the earlier of the next annual meeting of stockholders, the election of such director’s successor, or such director’s death, resignation or removal;
2.To ratify the appointment of Boulay PLLP as Celcuity’s independent registered public accounting firm for the year ending December 31, 2023;
3.To approve, on an advisory basis, named executive officer (NEO) compensation;
4.To approve a 1,500,000 share increase to the Celcuity Inc. Amended and Restated 2017 Stock Incentive Plan;
5.To transact any other business as may properly come before the meeting or any adjournments thereof, including matters incident to the conduct of the meeting.
|
| 2022-07-19 |
股东大会：
将于2022-09-01召开股东大会
会议内容 ▼▲
- 1.To approve an amendment to our Certificate of Incorporation to increase the authorized number of shares of Common Stock from 30,000,000 shares to 65,000,000 shares (the “Authorized Share Increase”);
2.To approve the adjournment of the Special Meeting to a later date and time, if necessary, to permit further solicitation and vote of proxies if, based upon the tabulated vote at the time of the Special Meeting, there are not sufficient votes to approve the Authorized Share Increase;
3.To transact any other business as may properly come before the meeting or any adjournments thereof, including matters incident to the conduct of the Special Meeting.
|
| 2022-04-11 |
股东大会：
将于2022-05-12召开股东大会
会议内容 ▼▲
- 1.To elect the six director nominees named in the Proxy Statement to the Celcuity Board of Directors, to serve until the earlier of the next annual meeting of stockholders, the election of such director’s successor, or such director’s death, resignation or removal;
2.To ratify the appointment of Boulay PLLP as Celcuity’s independent registered public accounting firm for the year ending December 31, 2022;
3.To approve, on an advisory basis, named executive officer compensation;
4.To approve a 500,000 share increase to the Celcuity Inc. Amended and Restated 2017 Stock Incentive Plan;
5.To approve an amendment to our Certificate of Incorporation to increase the authorized number of shares of Common Stock from 25,000,000 shares to 30,000,000 shares;
6.To transact any other business as may properly come before the meeting or any adjournments thereof, including matters incident to the conduct of the meeting.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-03-31 |
股东大会：
将于2021-05-12召开股东大会
会议内容 ▼▲
- 1.To elect the six director nominees named in the Proxy Statement to the Celcuity Board of Directors, to serve until the earlier of the next annual meeting of stockholders, the election of such director’s successor, or such director’s death, resignation or removal;
2.To ratify the appointment of Boulay PLLP as Celcuity’s independent registered public accounting firm for the year ending December 31, 2021;
3.To approve, on an advisory basis, named executive officer compensation;
4.To approve a 500,000 share increase to the Celcuity Inc. Amended and Restated 2017 Stock Incentive Plan;
5.To transact any other business as may properly come before the meeting or any adjournments thereof, including matters incident to the conduct of the meeting.
|
| 2020-03-31 |
股东大会：
将于2020-05-14召开股东大会
会议内容 ▼▲
- 1.To elect the six director nominees named in the Proxy Statement to the Celcuity Board of Directors, to serve until the earlier of the next annual meeting of stockholders, the election of such director’s successor, or such director’s death, resignation or removal;
2.To ratify the appointment of Boulay PLLP as Celcuity’s independent registered public accounting firm for the year ending December 31, 2020
3.To approve, on an advisory basis, named executive officer compensation;
4.To approve the Celcuity Inc. Amended and Restated 2017 Stock Incentive Plan;
5.To transact any other business as may properly come before the meeting or any adjournments thereof, including matters incident to the conduct of the meeting.
|
| 2019-04-03 |
股东大会：
将于2019-05-16召开股东大会
会议内容 ▼▲
- 1.To elect the five director nominees named in the Proxy Statement to the Celcuity Board of Directors, to serve until the earlier of the next annual meeting of stockholders, the election of such director’s successor, or such director’s death, resignation or removal;
2.To ratify the appointment of Boulay PLLP as Celcuity’s independent registered public accounting firm for the year ending December 31, 2019;
3.To approve, on an advisory basis, named executive officer compensation;
4.To transact any other business as may properly come before the meeting or any adjournments thereof, including matters incident to the conduct of the meeting.
|
| 2018-03-27 |
股东大会：
将于2018-05-10召开股东大会
会议内容 ▼▲
- 1.To elect the five director nominees named in this Proxy Statement to the Celcuity Board of Directors, to serve until the earlier of the next annual meeting of stockholders, such director’s successor has been duly elected, or such director’s death, resignation or removal;
2.To ratify the appointment by the Audit Committee of Celcuity’s Board of Directors of Boulay PLLP as Celcuity’s independent registered public accounting firm for the year ending December 31, 2018;
3.To approve, on a non-binding and advisory basis, named executive officer compensation;
4.To recommend, on a non-binding and advisory basis, the frequency of votes on named executive officer compensation;
5.To approve the Company’s 2017 Stock Incentive Plan;
6.To approve the Company’s 2017 Employee Stock Purchase Plan;
7.To approve an amendment to our Certificate of Incorporation to decrease the authorized number of shares of the Company’s Common stock from 45,000,000 shares to 25,000,000 shares and to reduce the authorized number of shares of the Company’s preferred stock from 5,000,000 shares to 2,500,000 shares;
8.To transact any other business as may properly come before the meeting or any adjournments thereof, including matters incident to the conduct of the meeting.
|